Grunhaus L, Dannon P N, Schreiber S, Dolberg O H, Amiaz R, Ziv R, Lefkifker E
Psychiatry Division, Sheba Medical Center, Ramat Gan, Israel.
Biol Psychiatry. 2000 Feb 15;47(4):314-24. doi: 10.1016/s0006-3223(99)00254-1.
Repetitive transcranial magnetic stimulation (rTMS), a new method for the stimulation of the central nervous system, is being proposed as a potential new treatment in patients with major depressive disorder (MDD). We tested the hypothesis that rTMS would be as effective as electroconvulsive therapy (ECT) in patients with MDD.
Forty patients with MDD referred for ECT were randomly assigned to either ECT or rTMS. Repetitive transcranial magnetic stimulation was performed at 90% power of the motor threshold. The stimulation frequency was 10 Hz for either 2 sec (first eight patients) or 6 sec (final 12 patients) for 20 trains. Patients were treated for up to 20 treatment days. Electroconvulsive therapy was performed according to standard protocols.
Overall patients responded best to ECT (chi(2) = 3.8, p <.05). Patients with MDD and psychosis responded significantly better to ECT (chi(2) = 9.2, p <. 01), whereas MDD patients without psychosis responded similarly to both treatments (chi(2) = 0.0, ns). The analysis of variance with repeated measures of clinical variables for the whole sample revealed significant treatment effects for both groups; however, interaction between group and treatment was seen only for the Global Assessment of Function and the Sleep assessment. When the psychosis-nonpsychosis grouping was considered, patients with psychosis responded dramatically better to ECT in all assessments, whereas those without psychosis responded similarly to both treatments.
Overall ECT was a more potent treatment for patients with MDD, this being particularly evident in patients with MDD and psychosis; however, in patients with MDD without psychosis the effects of rTMS were similar to those of ECT. The results we report are encouraging and support an important role for rTMS in the treatment of severe MDD; however, additional blinded studies are needed to precisely define this role.
重复经颅磁刺激(rTMS)是一种刺激中枢神经系统的新方法,正被提议作为重度抑郁症(MDD)患者的一种潜在新疗法。我们检验了rTMS在MDD患者中与电休克疗法(ECT)效果相同的假设。
40名因ECT前来就诊的MDD患者被随机分为ECT组或rTMS组。重复经颅磁刺激以运动阈值的90%功率进行。刺激频率为10赫兹,持续2秒(前8名患者)或6秒(最后12名患者),共20串。患者接受长达20个治疗日的治疗。电休克疗法按照标准方案进行。
总体而言,患者对ECT反应最佳(χ² = 3.8,p <.05)。伴有精神病的MDD患者对ECT反应明显更好(χ² = 9.2,p <.01),而无精神病的MDD患者对两种治疗的反应相似(χ² = 0.0,无显著性差异)。对整个样本临床变量进行重复测量的方差分析显示两组均有显著的治疗效果;然而,仅在功能总体评估和睡眠评估中发现组与治疗之间存在交互作用。当考虑精神病 - 非精神病分组时,在所有评估中,伴有精神病的患者对ECT反应显著更好,而无精神病的患者对两种治疗的反应相似。
总体而言,ECT对MDD患者是一种更有效的治疗方法,这在伴有精神病的MDD患者中尤为明显;然而,在无精神病的MDD患者中,rTMS的效果与ECT相似。我们报告的结果令人鼓舞,并支持rTMS在重度MDD治疗中的重要作用;然而需要更多的盲法研究来精确界定这一作用。